HIV Diagnostic

Clinical trial commences for HIV rapid test

Published in AIDS Weekly, August 16th, 2004

Chembio Diagnostics, Inc., (CEMI.OB) announced at the Fifteenth World Aids Conference that it has commenced clinical trials of the Sure Check HIV and HIV Stat-Pak - the company's proprietary lateral flow rapid tests for the detection of antibodies to HIV in finger stick whole blood, serum or plasma.

This is the initial step toward a Premarket Approval (PMA) application to the U.S. Food & Drug Administration. The clinical trials will be conducted at approved sites throughout the United States, in accordance with an Investigational Device Exemption (IDE), granted by the FDA to the company. Chembio Diagnostics, Inc., expects that the trials will be completed during the...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (2004-08-16)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry